{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:46:41Z","timestamp":1789631201287,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,14]]},"DOI":"10.1093\/eurheartj\/ehu374","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:09:01Z","timestamp":1409530141000},"page":"3365-3376","source":"Crossref","is-referenced-by-count":199,"title":["Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)"],"prefix":"10.1093","volume":"35","author":[{"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Popescu Mircea","family":"Ioachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Hvilsted","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vitali-Serdoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian","family":"Petrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Darabantiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,31]]},"reference":[{"key":"key\n\t\t\t\t20170515121445_EHU374C1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association","volume":"14","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170515121445_EHU374C2","first-page":"153","article-title":"Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice","volume":"45","year":"1995","journal-title":"Br J Gen Pract"},{"key":"key\n\t\t\t\t20170515121445_EHU374C3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/eurheartj\/ehs435","article-title":"Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515121445_EHU374C4","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515121445_EHU374C5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170515121445_EHU374C6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2013.12.022","article-title":"\u2018Real-world\u2019 antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey","volume":"127","year":"2014","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170515121445_EHU374C7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","year":"2010","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170515121445_EHU374C8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","year":"2010","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170515121445_EHU374C9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","year":"2010","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170515121445_EHU374C10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170515121445_EHU374C11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1160\/TH13-12-1007","article-title":"Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF Registry","volume":"111","year":"2014","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170515121445_EHU374C12","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","year":"2013","journal-title":"PloS One"},{"key":"key\n\t\t\t\t20170515121445_EHU374C13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2011.07.001","article-title":"Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF","volume":"162","year":"2011","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170515121445_EHU374C14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification","volume":"16","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170515121445_EHU374C15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1160\/TH14-01-0063","article-title":"Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation","volume":"111","year":"2014","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170515121445_EHU374C16","article-title":"Atrial fibrillation: the management of atrial fibrillation","author":"National-Institute-for-Health-and-Care-Excellence","year":"2014"},{"key":"key\n\t\t\t\t20170515121445_EHU374C17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/hrt.63.4.225","article-title":"Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin","volume":"63","year":"1990","journal-title":"Br Heart J"},{"key":"key\n\t\t\t\t20170515121445_EHU374C18","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehl015","article-title":"Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515121445_EHU374C19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ahj.2014.03.023","article-title":"Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the Veterans Health Administration","volume":"167","year":"2014","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170515121445_EHU374C20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/imj.12370","article-title":"Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice","volume":"44","year":"2014","journal-title":"Intern Med J"},{"key":"key\n\t\t\t\t20170515121445_EHU374C21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515121445_EHU374C22","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.amjcard.2014.01.002","article-title":"Atrial fibrillation and heart failure: a bad combination","volume":"113","year":"2014","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170515121445_EHU374C23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/clc.21008","article-title":"Statins reduce short- and long-term mortality associated with postoperative atrial fibrillation after coronary artery bypass grafting: impact of postoperative atrial fibrillation and statin therapy on survival","volume":"35","year":"2012","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t20170515121445_EHU374C24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/2047487313480435","article-title":"Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials","volume":"20","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"key\n\t\t\t\t20170515121445_EHU374C25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.ede.0000091649.26364.c0","article-title":"Rising rates of hospital admissions for atrial fibrillation","volume":"14","year":"2003","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t20170515121445_EHU374C26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/europace\/eur001","article-title":"Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation","volume":"13","year":"2011","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170515121445_EHU374C27","article-title":"Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores","year":"2014","journal-title":"Heart"},{"key":"key\n\t\t\t\t20170515121445_EHU374C28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/europace\/eut190","article-title":"CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy","volume":"16","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170515121445_EHU374C29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/heartjnl-2013-303695","article-title":"CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome","volume":"99","year":"2013","journal-title":"Heart"},{"key":"key\n\t\t\t\t20170515121445_EHU374C30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0b013e318287281b","article-title":"CHADS(2), CHA(2)S(2)DS(2)-VASc, and long-term stroke outcome in patients without atrial fibrillation","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170515121445_EHU374C31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1540-8167.2011.02257.x","article-title":"Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study","volume":"23","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20170515121445_EHU374C32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry","volume":"129","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515121445_EHU374C33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis\u2014Task Force on Anticoagulants in Heart Disease","volume":"110","year":"2013","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170515121445_EHU374C34","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1160\/TH13-07-0556","article-title":"Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation","volume":"110","year":"2013","journal-title":"Thromb Haemost"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/35\/47\/3365\/17051017\/ehu374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:47:06Z","timestamp":1503575226000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehu374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,31]]},"references-count":34,"journal-issue":{"issue":"47","published-online":{"date-parts":[[2014,8,31]]},"published-print":{"date-parts":[[2014,12,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehu374","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,31]]}}}